Metronidazol Heumann (Metronidazole)

Metronidazole enters microbial cells and is reduced under anaerobic conditions, forming free radicals that damage DNA and inhibit nucleic acid synthesis. This disruption leads to cell death in susceptible anaerobic bacteria and protozoa while sparing most human cells.

The specific dose and duration are determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal or hepatic function. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

The pregnancy category for metronidazole is listed as unknown, and safety data are limited. Use is generally reserved for situations where the potential benefit outweighs any possible risk. Breastfeeding mothers should consult their healthcare provider, as the drug can be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metronidazol Heumann shares the same class mechanism as other nitroimidazoles such as tinidazole. While both are effective against anaerobic bacteria and protozoa, metronidazole is more widely used and has a longer safety record. Tinidazole may have a longer half‑life, allowing less frequent dosing, but individual choice depends on clinical judgment and patient tolerance.

Metronidazol Heumann should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources to maintain product stability.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce gastrointestinal upset in some patients. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed.

Serious adverse events include seizures, severe allergic reactions such as anaphylaxis, and peripheral neuropathy, which may present as tingling or numbness. Patients should seek immediate medical attention if they experience any of these symptoms while on therapy.

Metronidazol Heumann is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazole compounds. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in those with a history of seizures unless benefits clearly outweigh risks.